Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 2
2014 2
2015 2
2016 5
2017 4
2018 4
2019 4
2020 4
2021 6
2022 4
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial.
Banerjee S, High J, Stirling S, Shepstone L, Swart AM, Telling T, Henderson C, Ballard C, Bentham P, Burns A, Farina N, Fox C, Francis P, Howard R, Knapp M, Leroi I, Livingston G, Nilforooshan R, Nurock S, O'Brien J, Price A, Thomas AJ, Tabet N. Banerjee S, et al. Among authors: nilforooshan r. Lancet. 2021 Oct 23;398(10310):1487-1497. doi: 10.1016/S0140-6736(21)01210-1. Lancet. 2021. PMID: 34688369 Free PMC article. Clinical Trial.
Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study).
Femminella GD, Frangou E, Love SB, Busza G, Holmes C, Ritchie C, Lawrence R, McFarlane B, Tadros G, Ridha BH, Bannister C, Walker Z, Archer H, Coulthard E, Underwood BR, Prasanna A, Koranteng P, Karim S, Junaid K, McGuinness B, Nilforooshan R, Macharouthu A, Donaldson A, Thacker S, Russell G, Malik N, Mate V, Knight L, Kshemendran S, Harrison J, Hölscher C, Brooks DJ, Passmore AP, Ballard C, Edison P. Femminella GD, et al. Among authors: nilforooshan r. Trials. 2019 Apr 3;20(1):191. doi: 10.1186/s13063-019-3259-x. Trials. 2019. PMID: 30944040 Free PMC article. Clinical Trial.
WhatsApp Doc?
Gould G, Nilforooshan R. Gould G, et al. Among authors: nilforooshan r. BMJ Innov. 2016 Jul;2(3):109-110. doi: 10.1136/bmjinnov-2016-000116. Epub 2016 Apr 12. BMJ Innov. 2016. PMID: 27547446 Free PMC article. No abstract available.
Perspectives and challenges in patient stratification in Alzheimer's disease.
Abdelnour C, Agosta F, Bozzali M, Fougère B, Iwata A, Nilforooshan R, Takada LT, Viñuela F, Traber M. Abdelnour C, et al. Among authors: nilforooshan r. Alzheimers Res Ther. 2022 Aug 13;14(1):112. doi: 10.1186/s13195-022-01055-y. Alzheimers Res Ther. 2022. PMID: 35964143 Free PMC article. Review.
A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trial.
Banerjee S, Farina N, Henderson C, High J, Stirling S, Shepstone L, Fountain J, Ballard C, Bentham P, Burns A, Fox C, Francis P, Howard R, Knapp M, Leroi I, Livingston G, Nilforooshan R, Nurock S, O'Brien J, Price A, Thomas AJ, Swart AM, Telling T, Tabet N. Banerjee S, et al. Among authors: nilforooshan r. Health Technol Assess. 2023 Oct;27(23):1-108. doi: 10.3310/VPDT7105. Health Technol Assess. 2023. PMID: 37929672 Free PMC article. Clinical Trial.
Technology integrated health management for dementia.
Rostill H, Nilforooshan R, Morgan A, Barnaghi P, Ream E, Chrysanthaki T. Rostill H, et al. Among authors: nilforooshan r. Br J Community Nurs. 2018 Oct 2;23(10):502-508. doi: 10.12968/bjcn.2018.23.10.502. Br J Community Nurs. 2018. PMID: 30290728 Clinical Trial.
42 results